Life at Extremes: Biology of Brine Pools and Methane Seeps One of our objectives in exploring the "New America" is to characterize the biology in some of the most extreme environments in the Gulf of Mexico, and that ... By: EVNautilus … Continue reading →

How to qualify CSIR NET life sciences - Group B evolution biology These CSIR NET life science lectures will explain how to qualify CSIR NET JRF/LS with tips and tricks discussed for group A, B and C of NET exam paper. For m... By: Suman Bhattacharjee … Continue reading →

Single-Cell Systems Biology of Signaling Networks in Human Disease Using Mass Cytometry Nature Webinar with Dr Jonathan Irish: Single cell systems biology of signaling networks in human disease using mass cytometry. By: fluidigm … Continue reading →

DAT biology section strategy/tips Several people were asking about how I had text notes read out loud to me while I did chores, drove, ect. Hopefully this will help explain how I did it. By: Andrew Wood … Continue reading →

San Francisco, California (PRWEB) July 14, 2014 The global market for computational biology is expected to reach USD 4,285.1 million by 2020 growing at a CAGR of 21.1%, according to a new study by Grand View Research, Inc. Steady increase in the usage & application of computational biology for bioinformatics R&D programs designed for sequencing genomes to better understand biological systems and increasing number of clinical studies in pharmacogenomics and pharmacokinetics for novel drug discovery studies are expected to drive computational biology demand over the next six years. Computational genomics for cellular and biological simulation applications dominated the market in 2013, accounting for over 47% of global revenue. Key factors driving demand for these applications include the growth of drug designing, disease modeling and personalized medicine applications and the growing usage of computational biology for functional and structural genomics, epigenomics and metagenomics for the analysis of protein transcription, protein-protein interactions, gene sequencing and expression and 3-dimensional protein structure analysis. The report Computational Biology Market Analysis By Application (Cellular & Biological Simulation, Pharmacogenomics, Drug Discovery, Drug Development, Lead Optimization, Lead Discovery, Pharmacokinetics, Pharmacodynamics, Disease Modeling, Clinical Trials), By Service (In-house, Contract), By End User (Academics, Industry, Commercial) And Segment Forecasts To … Continue reading →

Wellesley, Mass. (PRWEB) July 14, 2014 BCC Research (http://www.bccresearch.com) reveals in its new report, SYNTHETIC BIOLOGY: GLOBAL MARKETS, the global synthetic biology market is expected to grow to nearly $11.9 billion in 2018, with a five-year compound annual growth rate (CAGR) of 34.4%. Enabled products account for the fastest growing segment, with anticipated $9.7 billion in 2018 and 36.7% CAGR. Synthetic biology-enabled products in the pharmaceutical/diagnostics, chemical, energy, and agricultural industries compose the bulk of this market segment. Synthetic biology is an emerging biotechnology discipline with a wide range of applications. While there is enormous potential for future applications, it has a significant number of near-term commercial opportunities, and the list of new products and applications is continuously growing. Enabling products play a key role in the synthetic biology industry. Enabled products, the largest market segment, accounted for a value of $2.0 billion in 2013 and is expected to grow at a CAGR of 36.7% to reach a forecasted value of nearly $9.7 billion in 2018. Synthetic biology enabled products in the pharmaceutical/diagnostics, chemical, energy, and agricultural industries compose the bulk of this market segment. Enabling technologies and products are the engine that drives the development of the synthetic biology … Continue reading →